Craig Blanchette

SVP, Research at Switch Therapeutics

Craig is an experienced scientist and leader in the field of drug discovery, with expertise across multiple drug modalities including RNA and protein therapies. Craig led a drug discovery department at Genentech and played a leading role developing the RNA

therapeutic and delivery strategy. In addition to his experience in onboarding new modalities, he also has expertise in drug development of protein-based therapeutics across a broad range of therapeutic areas. Prior to joining Genentech, Craig was a staff

scientist in the Biological Sciences Department at Lawrence Livermore National Laboratories and led a team to build multiple vaccine programs using novel nanoparticle technology. He holds a Ph.D. in Biophysics from the University of California, Davis and a B.S. in Biology and Physics from Vassar College.

Links

Previous companies

Lawrence Livermore National Laboratory logo
Genentech logo

Timeline

  • SVP, Research

    March, 2023 - present